CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Other events
- 8-K Event Other events
- 4 Option exercise Director acquired 921 shares (option exercise)
- 4 Option exercise Director acquired 921 shares (option exercise)
- 4 Option exercise Director acquired 921 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 2,985 shares (option exercise)
- 4 Option exercise Director acquired 921 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 16,439 shares (option exercise)
- 4 Option exercise Director acquired 921 shares (option exercise)
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change
- 4 Option exercise Director acquired 922 shares (option exercise)
- 4 Option exercise Director acquired 922 shares (option exercise)
- 4 Option exercise Director acquired 922 shares (option exercise)
- 4 Option exercise Chief Executive Officer acquired 16,439 shares (option exercise)
- 4 Option exercise Director acquired 922 shares (option exercise)
Page 1 of 74 · 1,465 filings